Cargando…

Wide distribution of prion infectivity in the peripheral tissues of vCJD and sCJD patients

Sporadic Creutzfeldt-Jakob disease (sCJD) is the commonest human prion disease, occurring most likely as the consequence of spontaneous formation of abnormal prion protein in the central nervous system (CNS). Variant Creutzfeldt–Jakob disease (vCJD) is an acquired prion disease that was first identi...

Descripción completa

Detalles Bibliográficos
Autores principales: Douet, Jean-Yves, Huor, Alvina, Cassard, Hervé, Lugan, Séverine, Aron, Naima, Arnold, Mark, Vilette, Didier, Torres, Juan-Maria, Ironside, James W., Andreoletti, Olivier
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7882550/
https://www.ncbi.nlm.nih.gov/pubmed/33532912
http://dx.doi.org/10.1007/s00401-021-02270-x
_version_ 1783651072698482688
author Douet, Jean-Yves
Huor, Alvina
Cassard, Hervé
Lugan, Séverine
Aron, Naima
Arnold, Mark
Vilette, Didier
Torres, Juan-Maria
Ironside, James W.
Andreoletti, Olivier
author_facet Douet, Jean-Yves
Huor, Alvina
Cassard, Hervé
Lugan, Séverine
Aron, Naima
Arnold, Mark
Vilette, Didier
Torres, Juan-Maria
Ironside, James W.
Andreoletti, Olivier
author_sort Douet, Jean-Yves
collection PubMed
description Sporadic Creutzfeldt-Jakob disease (sCJD) is the commonest human prion disease, occurring most likely as the consequence of spontaneous formation of abnormal prion protein in the central nervous system (CNS). Variant Creutzfeldt–Jakob disease (vCJD) is an acquired prion disease that was first identified in 1996. In marked contrast to vCJD, previous investigations in sCJD revealed either inconsistent levels or an absence of PrP(Sc) in peripheral tissues. These findings contributed to the consensus that risks of transmitting sCJD as a consequence of non-CNS invasive clinical procedures were low. In this study, we systematically measured prion infectivity levels in CNS and peripheral tissues collected from vCJD and sCJD patients. Unexpectedly, prion infectivity was detected in a wide variety of peripheral tissues in sCJD cases. Although the sCJD infectivity levels varied unpredictably in the tissues sampled and between patients, these findings could impact on our perception of the possible transmission risks associated with sCJD. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1007/s00401-021-02270-x.
format Online
Article
Text
id pubmed-7882550
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Springer Berlin Heidelberg
record_format MEDLINE/PubMed
spelling pubmed-78825502021-02-25 Wide distribution of prion infectivity in the peripheral tissues of vCJD and sCJD patients Douet, Jean-Yves Huor, Alvina Cassard, Hervé Lugan, Séverine Aron, Naima Arnold, Mark Vilette, Didier Torres, Juan-Maria Ironside, James W. Andreoletti, Olivier Acta Neuropathol Original Paper Sporadic Creutzfeldt-Jakob disease (sCJD) is the commonest human prion disease, occurring most likely as the consequence of spontaneous formation of abnormal prion protein in the central nervous system (CNS). Variant Creutzfeldt–Jakob disease (vCJD) is an acquired prion disease that was first identified in 1996. In marked contrast to vCJD, previous investigations in sCJD revealed either inconsistent levels or an absence of PrP(Sc) in peripheral tissues. These findings contributed to the consensus that risks of transmitting sCJD as a consequence of non-CNS invasive clinical procedures were low. In this study, we systematically measured prion infectivity levels in CNS and peripheral tissues collected from vCJD and sCJD patients. Unexpectedly, prion infectivity was detected in a wide variety of peripheral tissues in sCJD cases. Although the sCJD infectivity levels varied unpredictably in the tissues sampled and between patients, these findings could impact on our perception of the possible transmission risks associated with sCJD. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1007/s00401-021-02270-x. Springer Berlin Heidelberg 2021-02-02 2021 /pmc/articles/PMC7882550/ /pubmed/33532912 http://dx.doi.org/10.1007/s00401-021-02270-x Text en © The Author(s) 2021 Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.
spellingShingle Original Paper
Douet, Jean-Yves
Huor, Alvina
Cassard, Hervé
Lugan, Séverine
Aron, Naima
Arnold, Mark
Vilette, Didier
Torres, Juan-Maria
Ironside, James W.
Andreoletti, Olivier
Wide distribution of prion infectivity in the peripheral tissues of vCJD and sCJD patients
title Wide distribution of prion infectivity in the peripheral tissues of vCJD and sCJD patients
title_full Wide distribution of prion infectivity in the peripheral tissues of vCJD and sCJD patients
title_fullStr Wide distribution of prion infectivity in the peripheral tissues of vCJD and sCJD patients
title_full_unstemmed Wide distribution of prion infectivity in the peripheral tissues of vCJD and sCJD patients
title_short Wide distribution of prion infectivity in the peripheral tissues of vCJD and sCJD patients
title_sort wide distribution of prion infectivity in the peripheral tissues of vcjd and scjd patients
topic Original Paper
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7882550/
https://www.ncbi.nlm.nih.gov/pubmed/33532912
http://dx.doi.org/10.1007/s00401-021-02270-x
work_keys_str_mv AT douetjeanyves widedistributionofprioninfectivityintheperipheraltissuesofvcjdandscjdpatients
AT huoralvina widedistributionofprioninfectivityintheperipheraltissuesofvcjdandscjdpatients
AT cassardherve widedistributionofprioninfectivityintheperipheraltissuesofvcjdandscjdpatients
AT luganseverine widedistributionofprioninfectivityintheperipheraltissuesofvcjdandscjdpatients
AT aronnaima widedistributionofprioninfectivityintheperipheraltissuesofvcjdandscjdpatients
AT arnoldmark widedistributionofprioninfectivityintheperipheraltissuesofvcjdandscjdpatients
AT vilettedidier widedistributionofprioninfectivityintheperipheraltissuesofvcjdandscjdpatients
AT torresjuanmaria widedistributionofprioninfectivityintheperipheraltissuesofvcjdandscjdpatients
AT ironsidejamesw widedistributionofprioninfectivityintheperipheraltissuesofvcjdandscjdpatients
AT andreolettiolivier widedistributionofprioninfectivityintheperipheraltissuesofvcjdandscjdpatients